WindRose-backed SubjectWell completed the merger with Clariness.

WindRose-backed SubjectWell, a company specializing in patient recruitment and clinical trial support, completed the merger with Clariness, a specialized provider of clinical trial recruitment and management services. Financial terms were not disclosed. "The combination of these two businesses under the Clariness brand creates a category-defining patient recruitment platform that is powered by innovation, data, and technology. Clariness' and SubjectWell's technology and breadth of capabilities bring much needed speed and efficiency to clinical research, delivering significant value to customers," CJ Burnes, WindRose Partner.